Shield Therapeutics PLC Stock
Your prediction
Shield Therapeutics PLC Stock
Heavy losses for Shield Therapeutics PLC today as the stock fell by -€0.030 (-24.590%).
Pros and Cons of Shield Therapeutics PLC in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
B****
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Shield Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Shield Therapeutics PLC | -24.590% | -9.804% | 50.820% | 211.864% | 222.807% | 52.066% | -87.895% |
| Card Factory plc | -0.930% | -2.574% | -0.376% | -12.397% | -6.360% | 25.148% | 129.437% |
| Pets At Home Group Ls 1 | -1.370% | -5.610% | -3.411% | -16.953% | -6.522% | -27.438% | -45.595% |
| Natural Grocers By Vit. Cot. | 4.670% | -5.882% | -18.248% | -46.411% | -40.107% | - | - |
News
Why Guardant Health Stock Surged Today
Shares of Guardant Health (NASDAQ: GH) rocketed 28% higher on Thursday after the precision oncology company reported outstanding growth metrics across its key product lines.
Image source: Getty
Guardant Health (GH) Q2 Revenue Up 31%
Guardant Health (NASDAQ:GH), a precision oncology company specializing in advanced cancer diagnostics and screening, reported results for the second quarter of fiscal 2025 on July 30, 2025. The